Logo image of ALBOU.PA

BOURRELIER GROUP (ALBOU.PA) Stock Fundamental Analysis

EPA:ALBOU - Euronext Paris - Matif - FR0000054421 - Common Stock - Currency: EUR

48  -1.6 (-3.23%)

Fundamental Rating

3

Taking everything into account, ALBOU scores 3 out of 10 in our fundamental rating. ALBOU was compared to 55 industry peers in the Specialty Retail industry. ALBOU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALBOU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALBOU had negative earnings in the past year.
In the past year ALBOU had a positive cash flow from operations.
ALBOU had positive earnings in each of the past 5 years.
In the past 5 years ALBOU always reported a positive cash flow from operatings.
ALBOU.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOU.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

With a Return On Assets value of -0.72%, ALBOU is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
The Return On Equity of ALBOU (-1.24%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -0.72%
ROE -1.24%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALBOU.PA Yearly ROA, ROE, ROICALBOU.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ALBOU's Profit Margin has declined in the last couple of years.
With a Gross Margin value of 37.89%, ALBOU perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
In the last couple of years the Gross Margin of ALBOU has grown nicely.
The Profit Margin and Operating Margin are not available for ALBOU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-54.12%
PM growth 5YN/A
GM growth 3Y-0.58%
GM growth 5Y2.23%
ALBOU.PA Yearly Profit, Operating, Gross MarginsALBOU.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

ALBOU does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALBOU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALBOU.PA Yearly Shares OutstandingALBOU.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALBOU.PA Yearly Total Debt VS Total AssetsALBOU.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.27 indicates that ALBOU is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.27, ALBOU is in line with its industry, outperforming 49.09% of the companies in the same industry.
ALBOU has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.40, ALBOU is in the better half of the industry, outperforming 69.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.27
ROIC/WACCN/A
WACC6.3%
ALBOU.PA Yearly LT Debt VS Equity VS FCFALBOU.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ALBOU has a Current Ratio of 2.95. This indicates that ALBOU is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.95, ALBOU belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
ALBOU has a Quick Ratio of 2.17. This indicates that ALBOU is financially healthy and has no problem in meeting its short term obligations.
ALBOU has a Quick ratio of 2.17. This is amongst the best in the industry. ALBOU outperforms 92.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.17
ALBOU.PA Yearly Current Assets VS Current LiabilitesALBOU.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALBOU have decreased strongly by -135.75% in the last year.
The earnings per share for ALBOU have been decreasing by -53.90% on average. This is quite bad
The Revenue has decreased by -2.02% in the past year.
The Revenue has been growing slightly by 6.13% on average over the past years.
EPS 1Y (TTM)-135.75%
EPS 3Y-53.9%
EPS 5YN/A
EPS Q2Q%-72.81%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y0.49%
Revenue growth 5Y6.13%
Sales Q2Q%-0.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBOU.PA Yearly Revenue VS EstimatesALBOU.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ALBOU.PA Yearly EPS VS EstimatesALBOU.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 0.5 1 1.5 2 2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBOU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBOU.PA Price Earnings VS Forward Price EarningsALBOU.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

72.73% of the companies in the same industry are more expensive than ALBOU, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.96
ALBOU.PA Per share dataALBOU.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBOU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOURRELIER GROUP

EPA:ALBOU (8/12/2025, 7:00:00 PM)

48

-1.6 (-3.23%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-18 2025-07-18
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap298.56M
Analysts34.29
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.01
P/FCF N/A
P/OCF 11.53
P/B 0.86
P/tB 0.98
EV/EBITDA 4.96
EPS(TTM)-0.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)4.16
OCFY8.68%
SpS47.33
BVpS55.77
TBVpS49.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.89%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-54.12%
PM growth 5YN/A
GM growth 3Y-0.58%
GM growth 5Y2.23%
F-Score2
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 6.82
Cap/Depr 89.16%
Cap/Sales 8.97%
Interest Coverage N/A
Cash Conversion 127.18%
Profit Quality N/A
Current Ratio 2.95
Quick Ratio 2.17
Altman-Z 2.27
F-Score2
WACC6.3%
ROIC/WACCN/A
Cap/Depr(3y)49.74%
Cap/Depr(5y)37.12%
Cap/Sales(3y)4.81%
Cap/Sales(5y)3.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.75%
EPS 3Y-53.9%
EPS 5YN/A
EPS Q2Q%-72.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y0.49%
Revenue growth 5Y6.13%
Sales Q2Q%-0.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-268.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-103.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.96%
OCF growth 3Y3.54%
OCF growth 5Y-15.14%